PATENT CLAIM ANALYSIS

Application Number: 15898153
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "04400A"]

Abstract:
Compounds, compositions and methods are provided for modulating the expression of transthyretin. The compositions comprise oligonucleotides, targeted to nucleic acid encoding transthyretin. Methods of using these compounds for modulation of transthyretin expression and for diagnosis and treatment of diseases and conditions associated with expression of transthyretin are provided.

Claim (Index 20):
The formulation of  claim 19 , wherein the modulator of transthyretin expression is an antisense compound, an antisense oligonucleotide, or a ribozyme capable of hybridizing to at least a portion of SEQ ID NO: 4.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 88.0
- Lexical Diversity: 1.60606
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12273731', '12710232', '10704263', '11556565', '11042768']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8020050604808353
- 35 USC 102 Novelty (BERT): 0.5622512311124856
- Combined Prediction Score: 0.7780296775440004
- Mean Citation Score: 248.125492
- Max Citation Score: 315.75513
- Similarity Product: 203.0054065468204

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test